UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Psychosocial and demographic predictors of quality of life in a large sample of cancer patients

Psycho-oncology (Chichester, England), 2003-03, Vol.12 (2), p.183-193

2003

Volltextzugriff (PDF)

Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings

Supportive care in cancer, 2007-05, Vol.15 (5), p.497-503

2007

Volltextzugriff (PDF)

Visualizing the target estimand in comparative effectiveness studies with multiple treatments

Journal of comparative effectiveness research, 2024-02, Vol.13 (2), p.e230089-e230089

2024

Volltextzugriff (PDF)

Neurofilament light levels are associated with long-term outcomes in multiple sclerosis

Multiple sclerosis, 2020-11, Vol.26 (13), p.1691-1699

2020

Volltextzugriff (PDF)

The use and quality of reporting of propensity score methods in multiple sclerosis literature: A review

Multiple Sclerosis Journal, 2022-08, Vol.28 (9), p.1317-1323

2022

Volltextzugriff (PDF)

Serum neurofilament light levels in natalizumab-treated patients with multiple sclerosis who switch to extended interval dosing from every-4-week dosing in real-world clinical practice

Multiple sclerosis, 2023-02, Vol.29 (2), p.196-205

2023

Volltextzugriff (PDF)

018 Disease control beyond NEDA: the value of non-clinical measures to determine treatment response to natalizumab

Journal of neurology, neurosurgery and psychiatry, 2022-06, Vol.93 (6), p.A19-A19

2022

Volltextzugriff (PDF)

Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring

Multiple sclerosis, 2021-09, Vol.27 (10), p.1497-1505

2021

Volltextzugriff (PDF)

A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis

Multiple sclerosis, 2020-08, Vol.26 (9), p.1064-1073

2020

Volltextzugriff (PDF)

Recommendations for the use of propensity score methods in multiple sclerosis research

Multiple sclerosis, 2022-08, Vol.28 (9), p.1467-1480

2022

Volltextzugriff (PDF)

Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation

Multiple sclerosis, 2023-08, Vol.29 (9), p.1070-1079

2023

Volltextzugriff (PDF)

Tobacco cessation education for pharmacists: Face-to-face presentations versus live webinars

Journal of the American Pharmacists Association, 2014, Vol.54 (1), p.42-44

2014

Volltextzugriff (PDF)

The effects of smoking deprivation and nicotine administration on emotional reactivity

Nicotine & tobacco research, 2006-06, Vol.8 (3), p.379-392

2006

Volltextzugriff (PDF)

Digital Devices for Assessing Motor Functions in Mobility-Impaired and Healthy Populations: Systematic Literature Review

Journal of medical Internet research, 2022-11, Vol.24 (11), p.e37683-e37683

2022

Volltextzugriff (PDF)

Predicting disability progression in multiple sclerosis: Insights from advanced statistical modeling

Multiple sclerosis, 2020-12, Vol.26 (14), p.1828-1836

2020

Volltextzugriff (PDF)

Methods for comparative effectiveness based on time to confirmed disability progression with irregular observations in multiple sclerosis

Statistical methods in medical research, 2023-07, Vol.32 (7), p.1284-1299

2023

Volltextzugriff (PDF)

Aucune différence relevée en termes d’activité radiologique entre les patients traités par natalizumab en administration à intervalles prolongés (EID) par rapport à l’administration à intervalles standard (SID) dans MS PATHS

Revue neurologique, 2021-04, Vol.177, p.S125-S125

2021

Volltextzugriff (PDF)

Time-dependence of hazard ratios for prognostic factors in primary breast cancer

Breast cancer research and treatment, 1998-01, Vol.52 (1-3), p.227-237

1998

Volltextzugriff (PDF)

Real-world effectiveness of dimethyl fumarate versus fingolimod in a cohort of patients with multiple sclerosis using standardized, quantitative outcome metrics

Multiple sclerosis journal - experimental, translational and clinical, 2022-01, Vol.8 (1), p.20552173211069852-20552173211069852

2022

Volltextzugriff (PDF)

Overall and patient-level comparative effectiveness of dimethyl fumarate and fingolimod: A precision medicine application to the Observatoire Français de la Sclérose en Plaques registry

Multiple sclerosis journal - experimental, translational and clinical, 2022-07, Vol.8 (3), p.20552173221116591-20552173221116591

2022

Volltextzugriff (PDF)

Impact du natalizumab sur la qualité de vie d’une cohorte en vie réelle de patients atteints de sclérose en plaques (SEP) : résultats de MS Partners Advancing Technology and Health Solutions (PATHS)

Revue neurologique, 2021-04, Vol.177, p.S126-S126

2021

Volltextzugriff (PDF)

Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial

Multiple sclerosis journal - experimental, translational and clinical, 2023-04, Vol.9 (2), p.20552173231169463-20552173231169463

2023

Volltextzugriff (PDF)

The effects of type of surgery and time on psychological adjustment in women after breast cancer treatment

Annals of surgical oncology, 2000-07, Vol.7 (6), p.427-434

2000

Volltextzugriff (PDF)

Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry

Multiple sclerosis journal - experimental, translational and clinical, 2023-07, Vol.9 (3), p.20552173231194353-20552173231194353

2023

Volltextzugriff (PDF)

1 – 25 von 184

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(162)
Mit Volltextzugriff
(142)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(110)
Science & Technology
(110)
Humans
(105)
Female
(76)
Male
(74)
Adult
(49)
Biological And Medical Sciences
(37)
Middle Aged
(37)
Adolescent
(36)
Medical Sciences
(35)
Clinical Neurology
(29)
Neurosciences & Neurology
(29)
Social Sciences
(29)
Child
(27)
Multiple Sclerosis
(25)
Public, Environmental & Occupational Health
(25)
Aged
(24)
Psychology
(22)
Surveys And Questionnaires
(20)
Psychology. Psychoanalysis. Psychiatry
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Psychosocial and demographic predictors of quality of life in a large sample of cancer patients

Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings

Visualizing the target estimand in comparative effectiveness studies with multiple treatments

Neurofilament light levels are associated with long-term outcomes in multiple sclerosis

The use and quality of reporting of propensity score methods in multiple sclerosis literature: A review

Serum neurofilament light levels in natalizumab-treated patients with multiple sclerosis who switch to extended interval dosing from every-4-week dosing in real-world clinical practice

018 Disease control beyond NEDA: the value of non-clinical measures to determine treatment response to natalizumab

Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring

A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis

Recommendations for the use of propensity score methods in multiple sclerosis research

Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation

Tobacco cessation education for pharmacists: Face-to-face presentations versus live webinars

The effects of smoking deprivation and nicotine administration on emotional reactivity

Digital Devices for Assessing Motor Functions in Mobility-Impaired and Healthy Populations: Systematic Literature Review

Predicting disability progression in multiple sclerosis: Insights from advanced statistical modeling

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)

Methods for comparative effectiveness based on time to confirmed disability progression with irregular observations in multiple sclerosis

Aucune différence relevée en termes d’activité radiologique entre les patients traités par natalizumab en administration à intervalles prolongés (EID) par rapport à l’administration à intervalles standard (SID) dans MS PATHS

Time-dependence of hazard ratios for prognostic factors in primary breast cancer

Real-world effectiveness of dimethyl fumarate versus fingolimod in a cohort of patients with multiple sclerosis using standardized, quantitative outcome metrics

Overall and patient-level comparative effectiveness of dimethyl fumarate and fingolimod: A precision medicine application to the Observatoire Français de la Sclérose en Plaques registry

Impact du natalizumab sur la qualité de vie d’une cohorte en vie réelle de patients atteints de sclérose en plaques (SEP) : résultats de MS Partners Advancing Technology and Health Solutions (PATHS)

Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial

The effects of type of surgery and time on psychological adjustment in women after breast cancer treatment

Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry

Suchergebnisse filtern